Maryland State Retirement & Pension System Uni Qure N.V. Transaction History

Maryland State Retirement & Pension System

$4.65 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$11.12 - $22.2 $5,582 - $11,144	-502 Reduced 2.99%	16,314 $186,000
Q4 2022 Jan 17, 2023	BUY	$18.12 - $27.32 $304,705 - $459,413	16,816 New	16,816 $0
Q1 2022 Apr 11, 2022	BUY	$14.54 - $21.5 $4,536 - $6,708	312 Added 2.21%	14,452 $261,000
Q3 2021 Oct 29, 2021	BUY	$26.01 - $38.22 $367,781 - $540,430	14,140 New	14,140 $453,000

Others Institutions Holding QURE

# of Institutions

153

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

Vestal Point Capital, LP New York, NY

4.75M
Shares

$27.5 Million
1.78% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.78M
Shares

$16.1 Million
0.81% of portfolio
Boxer Capital, LLC San Diego, CA

2.23M
Shares

$12.9 Million
0.58% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.19M
Shares

$12.7 Million
0.01% of portfolio
Abrdn PLC

1.93M
Shares

$11.1 Million
0.02% of portfolio

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $270M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland State Retirement & Pension System, based on Form 13F filings with the SEC.

News

Stay updated on Maryland State Retirement & Pension System with notifications on news.

Account